CenterWatch

Inflammatory Bowel Disease Clinical Trials

A listing of Inflammatory Bowel Disease medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter By:

 

Alabama

UPDATED

Huntsville Alabama 35802

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Mobile Alabama 36608

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Mobile Alabama 36608

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Mobile Alabama 36608

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Arizona

UPDATED

Scottsdale Arizona 85260

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Tucson Arizona 85724

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Tucson Arizona 85712

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Tucson Arizona 85712

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Tucson Arizona 85741

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

View More ▼

UPDATED

Tucson Arizona 85710

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Arkansas

UPDATED

Little Rock Arkansas 72205

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Little Rock Arkansas 72211

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

North Little Rock Arkansas 72117

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Sherwood Arkansas 72120

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

California

UPDATED

Bakersfield California 93301

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Garden Grove California 92845

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

La Jolla California 92037

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

La Mirada California 90638

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Laguna Hills California 92653

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

View More ▼

UPDATED

Los Angeles California 90067

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Los Angeles California 90045

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Mission Hills California 91345

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Northridge California 91324

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Oceanside California 92056

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Orange California 92868

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

San Carlos California 94070

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

San Diego California 92103

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Torrance California 90503

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

La Jolla California 92093-0956

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Oceanside California 92056

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Palo Alto California 94304

Patients are needed to participate in a clinical research study evaluating fecal calprotectin level for the treatment of Inflammatory Bowel Disease or Irritable Bowel Syndrome (IBS)

San Diego California 92103

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

San Diego California 92103

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

San Francisco California 94115

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

San Francisco California 94115

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

San Francisco California 94115

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Colorado

UPDATED

Denver Colorado 80045

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Littleton Colorado 80120

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Connecticut

UPDATED

Bristol Connecticut 06010

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Danbury Connecticut 06810

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Bristol Connecticut 06010

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Plainville Connecticut 06062

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Florida

UPDATED

Boca Raton Florida 33428

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Boynton Beach Florida 33426

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Clearwater Florida 33756

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Coral Gables Florida 33173

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Coral Springs Florida 33071

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

View More ▼

UPDATED

Hollywood Florida 33021

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Homestead Florida 33030

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Inverness Florida 34452

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease